The World Health Organization (WHO) on Wednesday recommended against using generic anti-parasite drug ivermectin in patients with Covid-19 except for clinical trials, because of a lack of data demonstrating its benefits.

The recommendation follows the European Medicines Agency's warning last week against the drug. The US Food and Drug Administration (FDA) has also recommended it not be used for Covid-19...